US Stock MarketDetailed Quotes

NGNE Neurogene

Watchlist
  • 30.320
  • -9.680-24.20%
Close Jun 18 16:00 ET
  • 30.100
  • -0.220-0.73%
Post 19:45 ET
393.56MMarket Cap-10706P/E (TTM)

About Neurogene Company

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in January 2018 and is headquartered in New York, NY.

Company Profile

SymbolNGNE
Company NameNeurogene
Listing DateMar 7, 2014
Founded2018
CEOMr. Richard K. Matros
MarketNASDAQ
Employees91
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address535 West 24th Street,5th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10011
Phone1-877-237-5020
Websitehttp://www.neurogene.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Rachel McMinn, PhD
  • Executive Chairman of the Board and Chief Executive Officer
  • 1.08M
  • Christine Mikail Cvijic, J.D.
  • President and Chief Financial Officer
  • 1.13M
  • Dr. Stuart Cobb, PhD
  • Chief Scientific Officer
  • 784.32K
  • Dr. Julie Jordan, M.D.
  • Chief Medical Officer
  • --
  • Donna Cochener
  • Senior Vice President and General Counsel
  • --
  • Dr. Robert A. Baffi,PhD
  • Independent Director
  • 64.08K
  • Dr. Cory Freedland, PhD
  • Independent Director
  • --
  • Rohan Palekar
  • Independent Director
  • 71.62K
  • Robert Keith Woods
  • Independent Director
  • --
  • Dr. Sarah B. Noonberg, M.D.,PhD
  • Independent Director
  • 62.12K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg